Kuros Back?

Seite 2 von 2
Neuester Beitrag: 13.03.24 10:07
Eröffnet am:25.09.19 14:02von: Zamorano1Anzahl Beiträge:30
Neuester Beitrag:13.03.24 10:07von: isostar100Leser gesamt:21.392
Forum:Börse Leser heute:6
Bewertet mit:

Seite: < 1 |

4296 Postings, 3356 Tage vinternet6,30

07.12.23 05:02

161 Postings, 1510 Tage LebakasJoeLöschung

12.12.23 11:38

Zeitpunkt: 17.12.23 14:19
Aktion: Löschung des Beitrages
Kommentar: Verbreitung von Desinformationen



5374 Postings, 951 Tage isostar100fokus auf magnet-os

27.12.23 07:50

grundsatzentscheidung bei kuros: fibrin wird quasi aufgegeben, fokus auf magnet-os.

Chris Fair, Chief Executive Officer of Kuros, said: “We are encouraged by the excellent results obtained with MagnetOs in both trials, and this, coupled with a recent interbody FDA clearance of MagnetOs, means that we now have level one clinical evidence of a best-in-class product to treat even difficult-to-heal patients. As a result, we have made the decision not proceed to Phase 3 with Fibrin-PTH and focus our investment and resources on the MagnetOs bone graft family of products. We are fortunate to have growing robust sales from MagnetOs to readily support our ongoing commercial and clinical operations.”  


5374 Postings, 951 Tage isostar100delighted

04.01.24 07:58

Chris Fair, Chief Executive Officer of Kuros, said: "We are delighted to have two MagnetOs products now cleared for interbody use, increasing the opportunity to serve our surgeon customers and the patients they treat.

Nachricht: Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA (11102507) - 04.01.24 - News

5374 Postings, 951 Tage isostar100153% wachstum in 2023

13.03.24 10:07
das biotechunternehmen kuros hat letztes jahr ein 153% wachstum hingelegt. bravo.


Angehängte Grafik:
screenshot_2024-03-13_at_10-05-....png (verkleinert auf 48%) vergrößern

Seite: < 1 |
   Antwort einfügen - nach oben